2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Drivers Are Shaping the Growth and Development of the Liver Cirrhosis Market?

The liver cirrhosis market is forecasted to flourish due to the rising consumption of alcohol. Alcohol consumption entails the quantity and regularity of alcoholic beverage intake. The surge in alcohol consumption can be attributed to its stress-alleviating effects, its role in bolstering social interactions at gatherings, its ability to heighten relaxation moments, and the continuous promotion and increased accessibility of it in various environments. Treatment for liver cirrhosis in individuals who heavily consume alcohol centers around managing liver damage through sobriety, medications, and supportive care, along with dealing with alcohol dependence through counseling and rehabilitation. For instance, the National Drugs Library, a data collection institution based in Ireland, reported in March 2023 that the per capita average alcohol consumption for people aged 15 years and above in 2022 stood at 10.2 liters of pure alcohol. This figure represented a 7.6% increase compared to the previous year. Hence, the upswing in alcohol consumption is fueling the growth of the liver cirrhosis market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22040&type=smp

#What is the Growth Potential of the Liver Cirrhosis Market, and How Will It Perform by 2034?

The market for liver cirrhosis has seen a swift expansion in recent years. The market, which is set to rise from $1.86 billion in 2024 to $2.01 billion in 2025, is expected to experience a compound annual growth rate (CAGR) of 8.3%. Various factors have led to the surge during the historic period which includes a rise in liver disease cases, excessive alcohol intake, an aging demographic, growing healthcare costs, and augmented initiatives from the government.

The market size for liver cirrhosis is projected to experience swift expansion in the upcoming years, crescendoing to $2.74 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 8.0%. The spike in growth during this forecast period can be linked to an increase in hepatitis infections, booming economic progress, heightened urbanization, modifications in lifestyle, and the rise of medical tourism. The forecast period is also likely to witness significant trends such as improved diagnostic tools, technological advancements, strategic collaborations and partnerships, the application of artificial intelligence, and the incorporation of all-inclusive therapies.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22040

Which Cutting-Edge Market Trends Are Expected to Drive the Liver Cirrhosis Market’s Growth?

Prominent players in the liver cirrhosis market are concentrating on innovative treatment approaches, such as the creation of active implantable medical devices, to enhance patient results and broaden treatment options. Active implantable medical devices are electronically powered implants configured to aid, monitor, or enhance the functioning of organs in the human body. For instance, in December 2024, the U.S. Food and Drug Administration approved the alfapump system of Sequana Medical NV, a medical device firm based in Belgium. This was the first active implantable medical device in the U.S for recurrent or refractory ascites management due to liver cirrhosis. This groundbreaking technology provides an automated, constant solution for fluid management by moving excess abdominal fluid to the bladder, significantly cutting down the reliance on invasive therapeutic paracentesis. Alfapump is a significant step forward in improving patient results and boosting quality of life, with a target market of roughly 70,000 patients in the United States.

What Are the Leading Market Players Impacting theLiver Cirrhosis Market’s Growth Trend?

Major companies operating in the liver cirrhosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Novo Nordisk A/S, Viatris Inc., Grifols Therapeutics LLC, Shionogi Inc., Galectin Therapeutics Inc., NGM Biopharmaceuticals Inc., Madrigal Pharmaceuticals Inc., Akero Therapeutics Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/liver-cirrhosis-global-market-report

How Are the Key Segments of the Liver Cirrhosis Market Driving Opportunities and Innovations?

The liver cirrhosis market covered in this report is segmented –

1) By Type: Alcoholic Cirrhosis, Atrophic Cirrhosis, Biliary Cirrhosis, Cardiac Cirrhosis, Cryptogenic Cirrhosis

2) By Treatment: Antibiotics, Immunosuppressants, Other Treatments

3) By End Users: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Academic And Research Institutes, Other End Users

Subsegmentss:

1) By Alcoholic Cirrhosis: Compensated Alcoholic Cirrhosis, Decompensated Alcoholic Cirrhosis, Alcoholic Steatohepatitis (ASH)-Associated Cirrhosis

2) By Atrophic Cirrhosis: Post-necrotic Atrophic Cirrhosis, Macronodular Atrophic Cirrhosis, Micronodular Atrophic Cirrhosis

3) By Biliary Cirrhosis: Primary Biliary Cirrhosis (PBC), Secondary Biliary Cirrhosis, Autoimmune Biliary Cirrhosis

4) By Cardiac Cirrhosis: Right Heart Failure-Induced Cirrhosis, Chronic Passive Congestion Cirrhosis, Ischemic Hepatitis Cirrhosis

5) By Cryptogenic Cirrhosis: Non-Alcoholic Steatohepatitis (NASH)-Associated Cirrhosis, Idiopathic Cirrhosis, Metabolic Syndrome-Associated Cirrhosis

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=22040&type=smp

What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theLiver Cirrhosis Market?# Market Expansion?

North America was the largest region in the liver cirrhosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver cirrhosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Liver Cirrhosis Market 2025, By The Business Research Company:

Liver Diseases Therapeutics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/liver-diseases-therapeutics-global-market-report

Liver Cancer Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/liver-cancer-diagnostics-global-market-report

Human Liver Model Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/human-liver-model-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: